Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Melanoma 13Neoplasms 5Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 2Kidney Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Skin Neoplasms 1Sexual Dysfunction, Physiological 1Sarcopenia 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Motor Activity 1Lung Squamous Cell Carcinoma Stage IV 1Locally Advanced Melanoma 1Locally Advanced Gastric Cancer 1Liver Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Eunuchism 1Esophageal Neoplasms 1Erectile Dysfunction 1

Interventions

Cetuximab 3pembrolizumab 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Squamous Cell × Nivolumab × Clear all
NCT06771674 2025-09-09

Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma

Hookipa Biotech GmbH

Completed
662 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡